The FDA’s Center for Drug Evaluation and Research (CDER) sent Nov. 27 Warning Letters to a sponsor and a clinical trial investigator as the result of Bioresearch Monitoring (BIMO) inspections. Applied Therapeutics, Inc., New York, N.Y., received a Warning Letter for allegedly failing to permit FDA investigators to have access to and copy and verify records and reports relatin... Read More